Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$33
-$27 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CWM, LLC holds $807,852,719 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
692,270 | $169,218,478 | |
| 2 | LLY |
ELI LILLY & Co
|
144,076 | $132,516,782 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,010,525 | $121,556,052 | |
| 4 | ABBV |
AbbVie Inc.
|
464,400 | $101,002,356 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,256,734 | $76,220,917 | |
| 6 | PFE |
Pfizer Inc
|
2,111,686 | $59,296,142 | |
| 7 | AMGN |
Amgen Inc
|
157,671 | $55,476,541 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
332,096 | $46,284,219 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33 | 5 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $60 | 5 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $98 | 5 | Shares | Sole | 2025-10-15 | |
| No filing history on record for this holder in this stock. | ||||||